$13.28
-0.19 (-1.41%)
As of Apr 2, 4:56 PM ET ·
RDY vs Pharmaceuticals Average
P/E Ratio
RDY 19.5
Avg 29.9
Profit Margin
RDY 17.3%
Avg -292.5%
Rev Growth
RDY +14.9%
Avg +18.9%
Div Yield
RDY 0.61%
Avg 2.95%

Pharmaceuticals Peers

1012 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
RDY Dr. Reddy's Laboratories $13.28 -1.41% 1.09T 19.5 17.3% +14.9% 0.61% Current
LLY Eli Lilly and Co. $935.58 -1.98% 883.95B 42.8 31.7% +31.7% 0.79% Strong buy Compare
JNJ Johnson & Johnson $243.04 -0.44% 585.70B 21.9 28.5% +5.6% 2.16% Buy Compare
MRK Merck & Co. Inc. $120.87 +0.02% 298.84B 16.4 28.1% +3.1% 2.84% Buy Compare
PFE Pfizer Inc. $28.32 -0.81% 153.76B 19.8 12.4% -14.8% 6.24% Hold Compare
BMY Bristol-Myers Squibb Co $59.60 -3.45% 119.16B 16.9 14.6% +1.5% 4.24% Hold Compare
ZTS Zoetis Inc $117.94 +0.55% 57.37B 21.5 28.2% +5.4% 1.64% Buy Compare
RPRX Royalty Pharma Plc- Cl A $48.57 +0.17% 20.81B 27.0 32.4% +2.1% 2.03% Strong buy Compare
VTRS Viatris Inc $13.44 -1.39% 15.47B -24.6% -4.2% 3.68% Buy Compare
RGC Regencell Bioscience Holding $30.80 -8.66% 15.23B 19.3% +1.6% Compare
JAZZ Jazz Pharmaceuticals Plc $186.95 -0.70% 11.51B -8.4% +5.3% Strong buy Compare
ELAN Elanco Animal Health Inc $23.08 -0.17% 11.47B -4.9% +2.3% Strong buy Compare
AXSM Axsome Therapeutics Inc $168.51 -1.91% 8.62B -28.7% +133.7% Strong buy Compare
TERN Terns Pharmaceuticals Inc $52.72 -0.13% 5.61B 32.1% -4.4% Strong buy Compare
CORT Corcept Therapeutics Inc $42.49 +1.21% 4.52B 45.4 13.1% +23.7% Strong buy Compare
LGND Ligand Pharmaceuticals $199.59 -0.02% 3.98B 32.0 46.4% +11.0% Strong buy Compare
AMRX Amneal Pharmaceuticals Inc $12.48 -1.81% 3.93B 54.5 2.4% +10.9% Strong buy Compare
CRNX Crinetics Pharmaceuticals In $37.23 +1.80% 3.90B -6,046.2% +17.5% Strong buy Compare
INDV Indivior Pharmaceuticals Inc $30.47 -0.59% 3.80B 30.4 0.3% +14.5% Strong buy Compare
EWTX Edgewise Therapeutics Inc $33.33 +0.57% 3.58B 17.7% +16.1% Strong buy Compare
LQDA Liquidia Corp $37.68 +0.56% 3.32B -43.5% +115.0% Strong buy Compare